958 related articles for article (PubMed ID: 25683490)
21. [Effect of tetrandine on gene expression of collagen type I, collagen type III and TGF-beta1 in scar tissue's of rabbits ear].
Zhou XL; Liu DW; Mao YG; Lü J
Zhonghua Zheng Xing Wai Ke Za Zhi; 2013 Nov; 29(6):406-12. PubMed ID: 24624876
[TBL] [Abstract][Full Text] [Related]
22. [Effects of sodium tanshinone II A sulfonate on proliferation of fibroblasts in scar and the mRNA and protein expressions of transforming growth factor beta 1 and alpha smooth muscle actin].
Liu H; Yang HL; Zhou SF; Meng CY
Zhonghua Shao Shang Za Zhi; 2013 Jun; 29(3):294-9. PubMed ID: 24059958
[TBL] [Abstract][Full Text] [Related]
23. Effect of Botulinum Toxin Type A on Differentiation of Fibroblasts Derived from Scar Tissue.
Jeong HS; Lee BH; Sung HM; Park SY; Ahn DK; Jung MS; Suh IS
Plast Reconstr Surg; 2015 Aug; 136(2):171e-178e. PubMed ID: 26218391
[TBL] [Abstract][Full Text] [Related]
24. The Effects of the Transforming Growth Factor-β1 (TGF-β1) Signaling Pathway on Cell Proliferation and Cell Migration are Mediated by Ubiquitin Specific Protease 4 (USP4) in Hypertrophic Scar Tissue and Primary Fibroblast Cultures.
Huang Y; Wang Y; Wang X; Lin L; Wang P; Sun J; Jiang L
Med Sci Monit; 2020 Apr; 26():e920736. PubMed ID: 32308208
[TBL] [Abstract][Full Text] [Related]
25. Smad ubiquitination regulatory factor 2 expression is enhanced in hypertrophic scar fibroblasts from burned children.
Zhang Z; Finnerty CC; He J; Herndon DN
Burns; 2012 Mar; 38(2):236-46. PubMed ID: 21920670
[TBL] [Abstract][Full Text] [Related]
26. Silencing NLRC5 inhibits extracellular matrix expression in keloid fibroblasts via inhibition of transforming growth factor-β1/Smad signaling pathway.
Ma HL; Zhao XF; Chen GZ; Fang RH; Zhang FR
Biomed Pharmacother; 2016 Oct; 83():1016-1021. PubMed ID: 27525969
[TBL] [Abstract][Full Text] [Related]
27. Kaempferol inhibits fibroblast collagen synthesis, proliferation and activation in hypertrophic scar via targeting TGF-β receptor type I.
Li H; Yang L; Zhang Y; Gao Z
Biomed Pharmacother; 2016 Oct; 83():967-974. PubMed ID: 27522259
[TBL] [Abstract][Full Text] [Related]
28. Salvianolic acid B inhibits myofibroblast differentiation and extracellular matrix accumulation in nasal polyp fibroblasts via the TGF-β1 signaling pathway.
Sun Z; Luo D; Wang S; Huang R; Dong P
Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33899116
[TBL] [Abstract][Full Text] [Related]
29. Imbalance between activin A and follistatin drives postburn hypertrophic scar formation in human skin.
Fumagalli M; Musso T; Vermi W; Scutera S; Daniele R; Alotto D; Cambieri I; Ostorero A; Gentili F; Caposio P; Zucca M; Sozzani S; Stella M; Castagnoli C
Exp Dermatol; 2007 Jul; 16(7):600-10. PubMed ID: 17576240
[TBL] [Abstract][Full Text] [Related]
30. [Role of p38 mitogen activated protein kinase on cyclic stretch in human facial hypertrophic scar fibroblasts differentiation into myofibroblasts].
Du QC; Xiao WL; Xue LF; Wang SY; Yue J; Xu YX
Zhonghua Kou Qiang Yi Xue Za Zhi; 2013 Oct; 48(10):615-20. PubMed ID: 24438570
[TBL] [Abstract][Full Text] [Related]
31. Periostin induces fibroblast proliferation and myofibroblast persistence in hypertrophic scarring.
Crawford J; Nygard K; Gan BS; O'Gorman DB
Exp Dermatol; 2015 Feb; 24(2):120-6. PubMed ID: 25421393
[TBL] [Abstract][Full Text] [Related]
32. Knockdown of IRF3 inhibits extracellular matrix expression in keloid fibroblasts.
Zhang Y; Zhang L; Lin XH; Li ZM; Zhang QY
Biomed Pharmacother; 2017 Apr; 88():1064-1068. PubMed ID: 28192879
[TBL] [Abstract][Full Text] [Related]
33. Functional characterization of TRAP1-like protein involved in modulating fibrotic processes mediated by TGF-β/Smad signaling in hypertrophic scar fibroblasts.
Wang X; Chu J; Wen CJ; Fu SB; Qian YL; Wo Y; Wang C; Wang DR
Exp Cell Res; 2015 Mar; 332(2):202-11. PubMed ID: 25655281
[TBL] [Abstract][Full Text] [Related]
34. Inhibitory effect of TGF-β peptide antagonist on the fibrotic phenotype of human hypertrophic scar fibroblasts.
Wang X; Gao Z; Wu X; Zhang W; Zhou G; Liu W
Pharm Biol; 2016 Jul; 54(7):1189-97. PubMed ID: 26135051
[TBL] [Abstract][Full Text] [Related]
35. Transforming growth factor-beta mRNA and protein in hypertrophic scar tissues and fibroblasts: antagonism by IFN-alpha and IFN-gamma in vitro and in vivo.
Tredget EE; Wang R; Shen Q; Scott PG; Ghahary A
J Interferon Cytokine Res; 2000 Feb; 20(2):143-51. PubMed ID: 10714549
[TBL] [Abstract][Full Text] [Related]
36. Bone marrow derived mesenchymal stem cells inhibit the proliferative and profibrotic phenotype of hypertrophic scar fibroblasts and keloid fibroblasts through paracrine signaling.
Fang F; Huang RL; Zheng Y; Liu M; Huo R
J Dermatol Sci; 2016 Aug; 83(2):95-105. PubMed ID: 27211019
[TBL] [Abstract][Full Text] [Related]
37. Cryptotanshinone downregulates the profibrotic activities of hypertrophic scar fibroblasts and accelerates wound healing: A potential therapy for the reduction of skin scarring.
Li Y; Shi S; Gao J; Han S; Wu X; Jia Y; Su L; Shi J; Hu D
Biomed Pharmacother; 2016 May; 80():80-86. PubMed ID: 27133042
[TBL] [Abstract][Full Text] [Related]
38. TNF-alpha suppresses alpha-smooth muscle actin expression in human dermal fibroblasts: an implication for abnormal wound healing.
Goldberg MT; Han YP; Yan C; Shaw MC; Garner WL
J Invest Dermatol; 2007 Nov; 127(11):2645-55. PubMed ID: 17554369
[TBL] [Abstract][Full Text] [Related]
39. [Expression of microRNA-296 in rabbit hypertrophic scars and its role to human fibroblasts].
Guo BY; Lin F; Bai ZM; Tao K; Wang HY
Zhonghua Shao Shang Za Zhi; 2021 Aug; 37(8):725-730. PubMed ID: 34404160
[No Abstract] [Full Text] [Related]
40. Silibinin inhibits myofibroblast transdifferentiation in human tenon fibroblasts and reduces fibrosis in a rabbit trabeculectomy model.
Chen YH; Liang CM; Chen CL; Chen JT; Chang YH; Lu DW; Chien KH; Tai MC
Acta Ophthalmol; 2013 Nov; 91(7):e506-15. PubMed ID: 23764119
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
